Here is your Forbes Daily Briefing for Wednesday, October 30th.

Today on Forbes, this startup has a new way to quit smoking.

Will this be the one that works?

Six years ago, in a townhouse in Santa Monica, Mario Danick began

tinkering on a device to help cigarette smokers quit. After buying nebulizers,

syringes, gaskets, battery packs, electrical firmware, and pharmaceutical-grade

nicotine liquid, Danick, who had recently sold his stake in a vaporizer company, took everything

apart and hacked together a functional prototype.

It wasn't pretty, but it worked.

The 39-year-old Danick says that the first device had a quote,

Frankenstein look. He quote I used a syringe as a

liquid vessel and there were a lot of external wires because I'm not good at

soldering. Dennick brought the prototype to Greg Smith, founder of Evolution Venture Capital in New York,

and he was intrigued enough to cut Danick a check along with San Francisco-based hedge fund Poseidon for $500,000, and Kunovia was born.

The company, which is based in Virginia, has since raised $35 million from investors that include Blueledge Capital, DJ Ventures, and Vice Ventures

at an estimated $350 million valuation.

Now, QNovia is hoping to become the newest player in the $3 billion in global annual sales

nicotine replacement therapy market, but it can't start selling its device in the U.S.

or booking revenue until it clears the food in drug

administration.

Cunovia was approved for an investigational new drug application by the

regulator in October and plans to start human clinical trials before the end of the year.

...